Cancer Multidisciplinary Meeting Data Standard

Page 1 of 4

Closes 26 Jun 2020

Your feedback

Please provide feedback on the relevant sections within the document. If including comments on specific data elements, please include either the heading name or number (eg: 3.2.1 or General practitioner or both).

General comments
3.1. Patient
3.2. General practitioner details
3.3. Core referral information and key questions
3.4. Clinical background
3.5. Family history
3.6. Current presentation
3.7. Staging information: Do you support the use of TNM staging as the preferred staging classification?
3.7. Staging information: For TNM stage, basis, and date neoadjuvant therapy modifier, should TX be included?
3.7.19. Other staging system: Are there any staging systems listed that should be removed as they are no longer in use?
3.7.19. Other staging system: Are there any staging systems that are not on the list that should be included?
3.7. Staging Information: other feedback
3.8. Pathology/radiology review
3.9. MDM Meeting details
3.10. MDM discussion and recommendations
3.11. Post-MDM patient consultation
3.12. Administration
4. Adoption roadmap